Biofilter Market Size To Grow At 9.8% CAGR Till 2033

Biofilter Market Size To Grow At 9.8% CAGR Till 2033

The biofilter market size was exhibited at USD 2.15 billion in 2024 and is projected to hit around USD 5.48 billion by 2034, growing at a CAGR of 9.8% during the forecast period 2024 to 2034.

Biofilter Market Key Takeaways:

  • The activated carbon biofilter segment held largest share of 24.2% of the biofilter market in 2024.
  • Biological aerated filter (BAFs) is the fastest-growing sub-segment in the market. It is expected to grow at a CAGR of 13.6% between 2025 and 2030.
  • The ceramic ring segment held the largest market share of 33.8% in 2024.
  • Bio balls are anticipated to witness a significant growth rate of 10.5% from 2024 to 2034.
  • Volatile organic compounds (VOC) treatment held the largest market share of 31.0% in in 2024.
  • Odor abatement is projected to have the fastest growth rate of 12.9% during the forecasted period.
  • Aquaculture segment held the largest market share of 23.7% in 2024.
  • North America biofilter market accounted for the largest share of 43.4% in the biofilter market in 2024.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report@?https://www.novaoneadvisor.com/report/sample/7888

The increasing applications for biofiltration are expected to drive the market's growth. Since, biofiltration has a wider application in wastewater treatment, gas and oil plants, petrochemicals, and paint industries, the growth remains promising.

Some examples of biofiltration are seaweeds, which filter pollutants released from the gills of fish and other aquaculture animals. According to research on horticulture from Penn State University, plant roots combined with limestone and soil can be used to create a biofilter to filter wastewater. Bacteria present in plant roots can eliminate pollutants and convert wastewater into a usable resource.

The increasing initiatives and funding programs by universities to accelerate research in biofiltration are expected to support market growth. For instance, in December 2022, Hawai’i Pacific University received USD 188,000 grant from the National Oceanic and Atmospheric Administration. The funding is to assist in the scientific assessment of the biofiltration capacity of the limu, and its growth rate.

Similarly, in December 2022, the U.S. Department of Energy awarded USD 280,861 to North Carolina Agricultural and Technical State University for developing a system for biofiltration-microalgae symbiotic and microalgae-based biochar-hydrogel-iron composite. The system and composite are intended to enhance microalgal production in wastewater.

Furthermore, the regulatory bodies in developed countries are undertaking stringent actions to implement biofiltration systems for improving water quality. For instance, in November 2022, the New York state Department of Environmental Conservation (DEC) penalized the New England Waste Services of NY, Inc., Ontario Count, and Casella Waste Services of Ontario, LLC, for violating various environmental laws. The operators and facility owners are expected to pay USD 500,000 as a penalty. Around USD 250,000 will be invested by the authorities in setting up a biofiltration system in the Marsh Creek wastewater treatment plant.??

Moreover, players in the market are constantly developing novel technologies to support biofiltration systems. At the Tekna aquaculture conference that was held in November 2022, NaturalShrimp, Inc. presented hydrogas and electrocoagulation technologies for the aquaculture industry. The technologies enable a system for zero liquid discharge without requiring water exchange to extract unnecessary nitrate buildup while using traditional methods of biofiltration. The development of novel technologies remains an integral part of the growth strategy in the industry.

Biofilter Market By Type Insights

The activated carbon biofilter segment held largest share of 24.2% of the biofilter market in 2024. The primary application of activated carbon biofilters is the treatment of municipal wastewater. Increasing environmental regulations, the need for efficient air and water purification, and technological advancements in filtration. Industrial expansion, especially in emerging economies, boosts demand for pollutant control solutions, while the focus on sustainability and green building initiatives further accelerates adoption. Additionally, activated carbon biofilters offer benefits such as cost-effectiveness and low-energy requirements, making them a preferred choice for industries aiming to reduce their environmental impact.

Biofilter Market By Filter Media Insights

The ceramic ring segment held the largest market share of 33.8% in 2024. It is considered to be significant biological filtration media for applications like filtration systems in aquariums. The ceramic ring filters the uneaten food waste, ammonia released from plant matter, and wastewater in fish tanks. Its advantages such as affordability, denitrifying bacteria, ease-of-use, long-lasting, and ease to clean application are expected to assist the segment to maintain its dominance during the forecast period.??

Biofilter Market By Application Insights

Volatile organic compounds (VOC) treatment held the largest market share of 31.0% in in 2024. Various industries such as automobiles are mandated to build VOC treatment plants by regulatory bodies. For instance, in April 2022, the Michigan Department of Environment ordered a motor parts manufacturer, ZF Active Safety U.S. Inc. to install a treatment system forchlorinated volatile organic compounds. Since the presence of VOC posed a threat of contamination to the water supply of Milford village.


Biofilter Market By End-use Insights

Aquaculture segment held the largest market share of 23.7% in 2024. The demand for biofilters for aquarium cleaning and filtration is growing which boosts the biofiltration industry. As per recent research, biofilter manufacturers are developing cost-effective recirculating aquaculture systems (RAS) for small capital investment in fish farming.? For instance, Aqua Shark Company collaborated with BioFishency company to develop simple operating RAS beneficial for fish farmers. The global biofilter industry is projected to exhibit significant growth in the upcoming years due to increased demand for fish farming. The market companies manufacturing biofilters mainly focus on improving the filtration rate and efficiency of the product and increasing sustainability. These factors enhance the overall productivity of the filters, which boosts the global biofiltration industry.

Biofilter Market By Regional Insights

North America biofilter market accounted for the largest share of 43.4% in the biofilter market in 2024, owing to the presence of major companies, extensive government funding, and an increase in research activities in the region. North America is the leading manufacturer of biofilters as the early implementation of biofiltration technique compared to other regions. The concept of self-cleaning aquariums with the application of biofiltration continues to boost market growth.

U.S. Biofilter Market Trends

U.S. biofilter market growth is primarily driven by stringent environmental regulations and the need for sustainable water and air treatment solutions, with advanced technologies enhancing efficiency in water purification and industrial processes.

Europe Biofilter Market Trends

The European biofilter market is growing due to strict environmental regulations and a focus on sustainable practices. Countries like Germany and the UK are leading in biofilter adoption for air and water treatment, driven by the need to reduce emissions and enhance water quality. Technological innovations and green initiatives further support market expansion across the region

Biofilter market in Germany is fueled by its technological advancements in biofilter materials and systems, particularly for industrial and municipal applications, backed by strict environmental policies

The UK biofilter market benefits from strong governmental policies aimed at reducing industrial emissions and promoting clean technologies, which are driving innovation in biofiltration for water and air quality management.

Asia Pacific Biofilter Market Trends

Asia Pacific is expected to grow at the highest rate during the forecasted period. Since the region is considered to be a major fishery market globally, contributing to the growth of the market. Moreover, rising environmental concerns and strict wastewater treatment regulations have boosted the growth of biofilter market in this region. Major countries such as China, Japan, and India are driving this growth through investments in sustainable technologies and infrastructure, making biofiltration an essential component for environmental compliance.

Japan biofilter market is expanding due to its focus on integrating biofilters with intelligent environmental control systems and the development of compact, high-capacity solutions for both industrial and household use

Biofilter market in China also has a high focus on wastewater treatment, with water treatment plants for wastewater treatment for about 98.1% of municipalities and around 28% of rural areas. China Biofilter market growth is influenced by its severe air and water pollution issues, leading to increased demand for efficient biofilters as part of large-scale environmental clean-up and industrial regulation initiatives

Middle East & Africa Biofilter Market Trends

Saudi Arabia biofilter market is growing due to the need for water treatment solutions in its arid climate, along with investments in sustainable technologies for industrial wastewater management

Biofilter market in UAE is growing due to the country's emphasis on innovative environmental solutions and sustainable development goals, with a focus on air quality improvement and wastewater treatment.

Some of the prominent players in the biofilter market include:

Biofilter Market Recent Development

  • In October 2024, Veolia Water Technologies opened a new Life Science center of excellence in Dublin, Ireland. This center is aimed at driving water treatment innovation, training, and growth in industries beyond the pharmaceutical, science, and healthcare industry in Europe.
  • In October 2024, Veolia Water Technology partnered with the University Area Joint Authority in State College, Pennsylvania, to implement its first biological hydrolysis system in North America. This collaboration aims to enhance decarbonized energy production in the region, supporting efforts to reduce carbon emissions and promote sustainable energy solutions.
  • In July 2024, Waterloo Biofilter Systems Inc. announced the acquisition of a specialist in advanced moving bed biofilm reactor technology, RH20, Inc. With this development, Waterloo expanded its technology portfolio.

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the biofilter market

By Type

  • Biological Aerated Biofilter System
  • Denitrification Biofilter Systems
  • Activated Carbon Biofilters
  • Fixed Films
  • Fluidized Bed Filter

By Filter Media

  • Ceramic Rings
  • Bio Balls
  • Moving Bed Filter Media
  • Others

By Application

  • VOC Treatment
  • Nitrification
  • Denitrification
  • Odor Abatement
  • Others

By End-use

  • Storm Water Management
  • Water & Wastewater collection
  • Chemical processing
  • ?Food & Beverage?
  • Aquaculture
  • Biopharma industry
  • Others

By Regional

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/7888

Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com

You can place an order or ask any questions, please feel free to [email protected] | +1 9197 992 333

About US

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Connect with Us

Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

IND Address: 707, Nandan Probiz, Baner,?Pune (MH) – 411045, India

USA:?+1 804 441 9344

APAC:?+61 485 981 310 or +91 87933 22019

Europe:?+44 7383 092 044

Email: [email protected]

Web: https://www.novaoneadvisor.com/

You can place an order or ask any questions, please feel free to contact at?[email protected] ?| +1 804 441 9344

Nova One Advisor Group Offer Other Reports:

Cell Therapy Market Size and Forecast:?The global?cell therapy market size was exhibited at USD 4.85 billion in 2023 and is projected to hit around USD 37.42 billion by 2033, growing at a CAGR of 22.67% during the forecast period 2024 to 2033.

Gene Therapy Market Size and Forecast?:?The global?gene therapy market size was exhibited at USD 8.75 billion in 2023 and is projected to hit around USD 52.40 billion by 2033, growing at a CAGR of 19.6% during the forecast period 2024 to 2033.

Cell And Gene Therapy Manufacturing Market Size and Forecast:?The global?cell and gene therapy manufacturing market size was estimated at USD 9.95 billion in 2023 and is projected to hit around USD 106.03 billion by 2033, growing at a CAGR of 26.7% during the forecast period from 2024 to 2033.

Cell and Gene Therapy Market?Size and Forecast:?The global?cell and gene therapy market size was estimated at USD 18.13 billion in 2023 and is projected to hit around USD 97.33 billion by 2033, growing at a CAGR of 18.3% during the forecast period from 2024 to 2033.

U.S. Cell Therapy Market Size and Forecast:?The?U.S. cell therapy market size was estimated at USD 2.88 billion in 2023 and is projected to hit around USD 19.67 billion by 2033, growing at a CAGR of 21.18% during the forecast period from 2024 to 2033.

U.S. Gene Therapy Market Size and Forecast:?The?U.S. gene therapy market size ?was estimated at USD 3.19 billion in 2023 and is projected to hit around USD 18.50 billion by 2033, growing at a CAGR of 19.22% during the forecast period from 2024 to 2033.

T-cell Therapy Market Size and Forecast:?The global?T-Cell therapy market size ?was exhibited at USD 3.85 billion in 2023 and is projected to hit around USD 79.62 billion by 2033, growing at a CAGR of 35.38% during the forecast period 2024 to 2033.

Cancer Immunotherapy Market?Size and Forecast:?The global?cancer immunotherapy market? size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.

Immunotherapy Drugs Market?:?The global?immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.

Clinical Trials Market Size and Forecast:?The?global clinical trials market size was estimated at USD 81.90 billion in 2023 and is projected to hit around USD 153.59 billion by 2033, growing at a CAGR of 6.49% during the forecast period from 2024 to 2033.

Biologics Market Size and Forecast: The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.

Biotechnology Market Size and Forecast:? The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.

Oncology? Market Size and Forecast: The?global oncology market size was estimated at USD 222.36 billion in 2023 and is projected to hit around USD 521.60 billion by 2033, growing at a CAGR of 8.9% during the forecast period from 2024 to 2033.

Cell And Gene Therapy Clinical Trials?Market Size and Forecast: The global cell and gene therapy clinical trials market size reached USD 11.62 billion in 2023 and is projected to hit around USD 47.40 billion by 2033, expanding at a CAGR of 15.09% during the forecast period from 2024 to 2033.

U.S. Clinical Trials Market Size and Forecast:?The?U.S. clinical trials market size was valued at USD 25.81 billion in 2023 and is projected to surpass around USD 41.57 billion by 2033, registering a CAGR of 4.88% over the forecast period of 2024 to 2033.

Active Pharmaceutical Ingredient CDMO Market:?The global active pharmaceutical ingredient CDMO market size was valued at USD 119.80 billion in 2023 and is anticipated to reach around USD 249.22 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.

U.S. Pharmaceutical Market?:?The U.S. pharmaceutical market size was valued at USD 602.19 billion in 2023 and is projected to surpass around USD 1,093.79 billion by 2033, registering a CAGR of 6.15% over the forecast period of 2024 to 2033.

Viral Vector And Plasmid DNA Manufacturing Market:?The global viral vector and plasmid DNA manufacturing market size ?was valued at USD 6.19 billion in 2023 and is anticipated to reach around USD 39.30 billion by 2033, growing at a CAGR of 20.3% from 2024 to 2033.

U.S. Viral Vector And Plasmid DNA Manufacturing Market ;?The U.S. viral vector and plasmid DNA manufacturing market size was valued at USD 2.45 billion in 2023 and is expected to be worth around USD 15.30 billion by 2033, with a registered CAGR of 20.1% during forecast period 2024 to 2033.

Compounding Pharmacies Market :?The global compounding pharmacies market size ?was valued at USD 16.19 billion in 2023 and is anticipated to reach around USD 30.97 billion by 2033, growing at a CAGR of 6.7% from 2024 to 2033.

U.S. Compounding Pharmacies Market?:?The U.S. compounding pharmacies market size ?is projected to be worth around USD 10.76 billion by 2033 from USD 6.31 billion in 2024, at a CAGR of 6.1% from 2024 to 2033.

Antibiotics Market: The?global antibiotics market size ?was valued at USD 51.19 billion in 2023 and is projected to surpass around USD 85.80 billion by 2033, registering a CAGR of 5.3% over the forecast period of 2024 to 2033.

Biologics Market :?The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.

Biotechnology Market:?The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.

Next Generation Sequencing Market?:?The?global next generation sequencing market size was estimated at USD 9.19 billion in 2023 and is projected to hit around USD 66.04 billion by 2033, growing at a CAGR of 21.8% during the forecast period from 2024 to 2033.

Genome Editing Market ;?The?global genome editing market size ?was valued at USD 8.45 billion in 2023 and is anticipated to reach around USD 40.48 billion by 2033, growing at a CAGR of 16.96% from 2024 to 2033.

U.S. Genome Editing Market:?The?U.S. genome editing market size was estimated at USD 3.55 billion in 2023 and is projected to hit around USD 16.49 billion by 2033, growing at a CAGR of 16.6% during the forecast period from 2024 to 2033.

U.S. Gene Synthesis Market?:?The?U.S. Gene Synthesis market size was valued at USD 700.90 million in 2023 and is projected to surpass around USD 3,118.73 million by 2033, registering a CAGR of 16.1% over the forecast period of 2024 to 2033.

Biopharmaceutical Market :?The global?Biopharmaceutical market size accounted for USD 327.46 billion in 2022 and is estimated to achieve a market size of USD 1,101.77 billion by 2032 growing at a CAGR of 12.9% from 2023 to 2032.

Immunotherapy Drugs Market?:?The?global immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.

Cancer Immunotherapy Market:?The global cancer immunotherapy market size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.

U.S. Plasmid DNA Manufacturing Market?:?The U.S. plasmid DNA manufacturing market size ?was valued at USD 711.90 million in 2023 and is projected to surpass around USD 4,885.15 million by 2033, registering a CAGR of 21.24% over the forecast period of 2024 to 2033.

U.S. Precision Medicine Market?:?The?U.S. precision medicine market size was valued at USD 24.95 billion in 2023 and is projected to reach around USD 76.12 billion by 2033, registering a CAGR of 11.80% from 2024 to 2033.

要查看或添加评论,请登录

Ramchandra Dige的更多文章